Annual report [Section 13 and 15(d), not S-K Item 405]

Note 16 - Income Taxes - Deferred Tax Assets (Details)

v3.25.1
Note 16 - Income Taxes - Deferred Tax Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Notes To Financial Statements [Abstract]    
Net operating losses carried forward $ 79,951 $ 73,552
Research and development expenditures 5,016 5,025
Property, equipment, and other intangible assets 7,265 7,321
Research and development tax credits 4,864 4,930
Financing costs 909 431
Right-of-use assets 13 19
Total deferred tax assets 98,018 91,278
Valuation allowance (98,018) (91,278)
Net deferred tax asset $ 0 $ 0